Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension

Pierangelo Chinello, Stefania Cicalini, Andrea Cortese, Maria Paola Cicini, Nicola Petrosillo

Research output: Contribution to journalArticlepeer-review


We present the case of an HIV/HCV-coinfected patient with HIV-related pulmonary hypertension (HRPH) who experienced a good clinical and functional response to bosentan, with a subsequent switch to oral sildenafil due to increased transaminase levels. Bosentan resulted less handy in this case, probably due to both side effects and co-morbidities.

Original languageEnglish
Article numbere14
JournalInfectious Disease Reports
Issue number2
Publication statusPublished - 2011


  • Bosentan
  • HIV
  • Pulmonary arterial hypertension
  • Sildenafil

ASJC Scopus subject areas

  • Infectious Diseases


Dive into the research topics of 'Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension'. Together they form a unique fingerprint.

Cite this